|
US2005222434A1
|
|
Acid-sensitive compounds, their preparation and uses
|
|
AU2004201075A1
|
|
Method for producing recombinant adenovirus
|
|
HK1059799A1
|
|
Purification of a triple heli formation with an immobilized oligonucleotide
|
|
WO03012113A2
|
|
Inducible expression systems employing ppar transcriptional activators
|
|
CA2446951A1
|
|
Polythiourea lipid derivatives
|
|
CA2440133A1
|
|
Methods for purifying and detecting double stranded dna target sequences by triple helix interaction
|
|
IL155699D0
|
|
Neutral and anionic colloidal particles for gene delivery
|
|
US6825012B2
|
|
DNA molecules, preparation and use in gene therapy
|
|
IL154736D0
|
|
Acid-sensitive compounds, preparation and uses thereof
|
|
IL154508D0
|
|
System for regulating in vivo the expression of a transgene by conditional inhibition
|
|
AU5597501A
|
|
Method for producing recombinant adenovirus
|
|
HU9902571A2
|
|
Variants of thymidine kinase, related nucleic acids sequences and their use in genic therapy
|
